• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Clinical Digital Resource Collaborative

Clinical Digital Resource Collaborative

Designed and developed in the North East and North Cumbria by local GPs

National Health Service
  • Home
  • About Us
  • The Team
  • Resources
    • Referral Forms
    • EMIS Resources
      • CDRC EMIS Access
      • Long Term Condition (LTC) Management
      • Impact and Investment Fund (IIF)
      • Medicine Management
        • Precision Monitoring
        • DMARDs and High Risk Drugs
        • Safe Prescribing of Opioids / Opiates
      • Specialties
        • Cancer Guide for EMIS
        • EMIS Cardiovascular Overview
          • Atrial Fibrillation Guide for EMIS
          • CDRC Precision CVD Prevention Template
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS
          • Peripheral Arterial Disease EMIS Guide
        • Infection
          • Infections Guide for EMIS
          • Blood Borne Virus (BBV)
        • Neurology Guide for EMIS
        • Respiratory Overview
          • BeatAsthma+
    • SystmOne Resources
      • National Early Warning Score 2 (NEWS2) Guide for SystmOne
      • Getting Started
        • Getting Started – Access
        • Getting Started – How-To’s
      • SystmOne Administration
      • Contract Management
        • Batch Reporting
        • Impact and Investment Fund (IIF)
        • Vaccinations
      • Long Term Condition Management
        • Call/ Recall System
        • Recall Recovery System
        • Care Planning
      • Safeguarding System
        • Safeguarding Adults
        • Safeguarding At Risk of Harming Others
        • Safeguarding Family/Household Cause for Concern
        • Safeguarding Children
      • Medicine Management
        • Drugs Requiring Monitoring System
        • Safety & Reviews
        • Safe Prescribing of Opioids/ Opiates
        • Safe Prescribing of NSAIDS
        • Safe Prescribing of Lithium
        • Safe Prescribing of Valproate
        • Safe Prescribing of Corticosteroids / Steroids
      • Specialties
        • Blood Borne Virus (BBV) Test Alert for SystmOne
        • BeatAsthma+ Guide for SystmOne
        • Cancer Overview
          • Cancer
          • Suspected Cancer
        • Cardiovascular Overview
          • Cardiology Results
          • Hypertension & Blood Pressure
          • Atrial Fibrillation (AF)
          • Integrated CVD Prevention
          • Peripheral Arterial Disease (PAD)
        • ENT Infections
        • Geriatrics Overview
          • Care for Frail Patients
          • Comprehensive Geriatric Assessment
          • Co-ordinated Care
        • Haematology
        • Infection Overview
        • Learning Disabilities
        • Lifestyle
        • Lipids, Familial Hypercholesterolemia, PCSK9i & Inclisiran Overview
          • Performance Searches
          • Quality Improvement
          • Statin Safety
          • Lipids Protocols
          • Lipids Opt-In Resources
          • Lipids Details Template
          • Lipid Lowering Template
          • Lipid QoF Support
          • Screening for Familial Hypercholesterolaemia
          • Aetiology of Abnormal Lipids
          • Lipids Strategy
          • Lipids – Recommended Batch Searches
        • MSK Referral Management
        • Neurology
        • Obesity Resources
        • Ophthalmology
        • Palliative Care
        • Respiratory Overview
          • Asthma Resources
          • Respiratory Infections
        • Rheumatology Overview
          • Bone Health
      • Women’s Health Overview
        • Gynaecology Resource Overview
          • Cervical Screening
          • Contraception
          • Prolapse
      • Vaccination Overview
        • COVID-19 Resources- SystmOne
        • Influenza Vaccination
        • Meningitis B Vaccination
        • Meningitis ACWY Vaccination
        • Pneumococcal Vaccination
        • Shingles Vaccination
  • FAQs
  • News and Events
    • Demonstrations
    • Events
      • Recordings
    • Articles
    • Conference abstracts
  • Contact us
You are here: Home / Resources / SystmOne Resource Centre / SystmOne Specialties / Rheumatology Overview / Bone Health

Bone Health

Safe Prescribing of Denosumab

The CDRC module for Denosumab prescribing aims to maximise safety and concordance with guidelines for using this drug.   

Set-up
  1. Create a Recall Type with the following properties 
  1. Ensure that all patients who are receiving denosumab have this medication included on their repeat medication list. This forms your denosumab ‘register’. The quality search CDRC Quality > Rheumatology > DENOS02 will identify patients who have been given an acute script for denosumab in the previous 6 months but do not have this on their repeat medication. DENOS03 will identify those who had a script between 6 and 10 months ago but not currently on their repeat medication list: this might be because they have stopped the denosumab or been lost to follow up. 
  2. Ensure all patients on repeat denosumab have a denosumab recall.  The DENOS04 will identify patients who need to have a recall added (NB will not function fully until the day after you have completed step 2. 
Recall

A specific report will identify patients who are due to have a denosumab injection within the next two weeks (or have not yet attended for an overdue injection).  This report can be found at: 

CDRC > Recall Setup > Recall Injection Denosumab (before two weeks hence) 

Alternatively, you can use a report that identifies patients who need any regular injection e.g. GnRH analogues, depo-provera, B12.  This report can be found at: 

CDRC > Recall Setup > Recall Any Injection 

You could also create your own bespoke report to include any combination of the injection recalls available.  It is a good idea to create a batch report so these reports are run weekly and lead to an automatic task to an administrator to ensure that an appointment(s) is/has been made for injection and/or monitoring  and that any appropriate medications are in stock. 

Alerts

Patients with denosumab on repeat prescription will have a ‘drugs requiring monitoring’ icon:

Patients on denosumab with up to date monitoring:

Patients on denosumab but monitoring is out of date 

Clicking on the icon will launch the DRM (drugs requiring monitoring) template showing which relevant drugs the patient is on. 

Patient Review

From the nursing master template click on the Denosumab monitoring button. 

  1. Description of monitoring requirements 
  2. Link to the local denosumab guidelines 
  3. Most recent monitoring results 
  4. Information about current calcium and vitamin D intake 
  5. Link to vitamin D and calcium template 
  6. Current pending denosumab recall – missing in the example shown 
  7. Current repeat templates for denosumab and previous issues 
  8. Summary of important information 

To conduct a denosumab review: 

  • Ensure that monitoring is up to date 
  • Check that the information about calcium and vitamin D intake is appropriate 
  • Check that the information in the bottom panel is up to date and complete.  If this panel is empty, click on the DRM Denosumab button to complete the denosumab questionnaire.  If this panel already has information but needs updating, right click on the panel and choose Copy Questionnaire then choose Copy Comments then update the information before completing the questionnaire choosing the Save Final Version option 
  • Administer the injection 
  • Right click on the Denosumab recall and choose Seen before setting the date for the next recall. 

Calcium and Vitamin D 

Patients on denosumub must have adequate vitamin D and calcium intake to avoid hypocalcaemia.  Calcium and vitamin D intake will be displayed on the denosumab template with a link to the calcium and vitamin D template (above).  Here you can calculate calcium intake using an online calculator and record this information.  Information about dietary and supplementary calcium and vitamin D intake will then be displayed on the denosumab template. 

Quality Control Reports

The following quality control reports can be found in the CDRC Quality > Rheumatology folder or on the QC page of the denosumab template. 

Report NamePatients Returned
DENOS01 Denosumab RegisterThis counts patients with a repeat script for denosumab
DENO02 Denosumab not on repeatPatients who should have denosumab added to their repeats. Patients who have been given an acute script for denosumab in the last 6 months but this is not included in their repeat medication 
DENO03 Missed denosumabPatients who may have been lost to follow up.  Identifies patients who have had densoumab between 6 and 10 months ago but it is not included on their repeat list.  Patients whose denosumab has been stopped deliberately will appear on this list for four months. 
DENO04 Denosumab repeat but no recallPatients on the denosumab register who do not have an appropriate denosumab recall 
DENO05 Denosumab repeat but no apparent indicationPatients on denosumab without osteoporosis or androgen deprivation therapy – to identify patients where denosumab therapy might be inappropriate 
DENO06 Denosumab repeat but monitoring up to datePatients on denosumab without a measurement of calcium and renal function in the last 6 months (and vitamin D for Newcastle patients). You will not need to run this report if you already run the DRM Monitoring overdue report as it will automatically be included in that. 
DENO07 Denosumab and last calcium lowPatients on denosumab whose last calcium was low 
DENO08 Denosumab but not adequate calcium/vit D intakeDENOS08 – patient on denosumab who do not have: 
Calcium supplement or code for high dietary calcium intake within 12m 
Vitamin D supplement or code for vitamin D intake within 12m 

Ideally these reports should be added to a batch report that sends a regular (monthly or bimonthly) task to an administrator to arrange review of the appropriate patients records. 

Footer

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter
  • Terms of Reference
  • Ethics & Governance
  • Privacy policy
  • Terms of use
  • Join CDRC Precision

Copyright © 2023 Clinical Digital Resource Collaborative